0

(−)-Sparteine

INQUIRY Add to cart
For Research Use Only | Not For Clinical Use
CATAP90391
CAS90-39-1
Structure
MDL NumberMFCD00069653
Molecular Weight234.38
EC Number201-988-8
InChI KeySLRCCWJSBJZJBV-ZQDZILKHSA-N
Description≥98.0% (GC)
Density1.02 g/mL at 25 °C (lit.)
Assay≥98.0% (GC)
BP137-138 °C/1 mmHg (lit.)
Refractive Indexn20/D 1.526-1.530; n20/D 1.528 (lit.)
Size100MG
1

Asymmetric Deprotonation Using s-BuLi or i-PrLi and Chiral Diamines in THF: The Diamine Matters

Giorgio Carbone, Peter O'Brien, Göran Hilmersson

J Am Chem Soc. 2010 Nov 3;132(43):15445-50.

PMID: 20936816

1

C2-Modified Sparteine Derivatives Are a New Class of Potentially Long-Acting Sodium Channel Blockers

Vaibhavkumar S Gawali, Svilen Simeonov, Martina Drescher, Thomas Knott, Olaf Scheel, John Kudolo, Hanspeter Kählig, Ulla Hochenegg, Alexander Roller, Hannes Todt, Nuno Maulide

ChemMedChem. 2017 Nov 22;12(22):1819-1822.

PMID: 29045055

1

Dichloro[(6R,7S,8S,14S)-(-)-sparteine-kappa2N,N']mercury(II)

Sung-Nak Choi, Sang-Yub Kim, Hae-Wook Ryu, Yong-Min Lee

Acta Crystallogr C. 2005 Dec;61(Pt 12):m504-6.

PMID: 16330831

1

Gram-Scale Synthesis of the (-)-Sparteine Surrogate and (-)-Sparteine

James D Firth, Steven J Canipa, Leigh Ferris, Peter O'Brien

Angew Chem Int Ed Engl. 2018 Jan 2;57(1):223-226.

PMID: 29155468

1

Sparteine as an Anticonvulsant Drug: Evidence and Possible Mechanism of Action

Fridha Villalpando-Vargas, Laura Medina-Ceja

Seizure. 2016 Jul;39:49-55.

PMID: 27262285

  • Verification code
Contact Us

Send Us a Request

What is your specific need? We will do everything we can to meet your expectations.
Online Inquiry

Online Inquiry

For any inquiry, question or recommendation, please call: or fill out the following form.

  • Verification code

Head Office

  • Tel:
  • Email:

Follow us on

qrcode